Literature DB >> 35105958

Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH.

Yu-Feng Li1, Zhi-Fu Xie1, Qian Song1,2, Jing-Ya Li3,4,5.   

Abstract

Mitochondrial biology and behavior are central to the physiology of liver. Multiple mitochondrial quality control mechanisms remodel mitochondrial homeostasis under physiological and pathological conditions. Mitochondrial dysfunction and damage induced by overnutrition lead to oxidative stress, inflammation, liver cell death, and collagen production, which advance hepatic steatosis to nonalcoholic steatohepatitis (NASH). Accumulating evidence suggests that specific interventions that target mitochondrial homeostasis, including energy metabolism, antioxidant effects, and mitochondrial quality control, have emerged as promising strategies for NASH treatment. However, clinical translation of these findings is challenging due to the complex and unclear mechanisms of mitochondrial homeostasis in the pathophysiology of NASH.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  NASH; liver; metabolism; mitochondria; mitochondrial homeostasis

Mesh:

Year:  2022        PMID: 35105958      PMCID: PMC9061859          DOI: 10.1038/s41401-022-00864-z

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  219 in total

Review 1.  Mitochondrial protein import: from proteomics to functional mechanisms.

Authors:  Oliver Schmidt; Nikolaus Pfanner; Chris Meisinger
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09       Impact factor: 94.444

2.  ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy.

Authors:  Wenxian Wu; Weili Tian; Zhe Hu; Guo Chen; Lei Huang; Wen Li; Xingli Zhang; Peng Xue; Changqian Zhou; Lei Liu; Yushan Zhu; Xingliang Zhang; Longxuan Li; Liangqing Zhang; Senfang Sui; Bin Zhao; Du Feng
Journal:  EMBO Rep       Date:  2014-03-26       Impact factor: 8.807

3.  Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.

Authors:  Mary E Rinella; M Shaddab Siddiqui; Konstantina Gardikiotes; Jeanne Gottstein; Marc Elias; Richard M Green
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

4.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

5.  Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.

Authors:  Chrysi Koliaki; Julia Szendroedi; Kirti Kaul; Tomas Jelenik; Peter Nowotny; Frank Jankowiak; Christian Herder; Maren Carstensen; Markus Krausch; Wolfram Trudo Knoefel; Matthias Schlensak; Michael Roden
Journal:  Cell Metab       Date:  2015-05-05       Impact factor: 27.287

6.  MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.

Authors:  Dimitrios Iliopoulos; Konstantinos Drosatos; Yaeko Hiyama; Ira J Goldberg; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

7.  Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.

Authors:  Manal F Abdelmalek; Schuyler O Sanderson; Paul Angulo; Consuelo Soldevila-Pico; Chen Liu; Joy Peter; Jill Keach; Matt Cave; Theresa Chen; Craig J McClain; Keith D Lindor
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

8.  Multiple dynamin family members collaborate to drive mitochondrial division.

Authors:  Jason E Lee; Laura M Westrate; Haoxi Wu; Cynthia Page; Gia K Voeltz
Journal:  Nature       Date:  2016-10-31       Impact factor: 49.962

Review 9.  The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Ji-Young Cha; Da-Hyun Kim; Kyung-Hee Chun
Journal:  Lab Anim Res       Date:  2018-12-31

Review 10.  Mitochondrial transcription and translation: overview.

Authors:  Aaron R D'Souza; Michal Minczuk
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

View more
  2 in total

Review 1.  Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease.

Authors:  Robert W M Min; Filbert W M Aung; Bryant Liu; Aliza Arya; Sanda Win
Journal:  Biomedicines       Date:  2022-08-20

2.  Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of "PCOS Males".

Authors:  Katarzyna J Siemienowicz; Panagiotis Filis; Jennifer Thomas; Paul A Fowler; W Colin Duncan; Mick T Rae
Journal:  Biomedicines       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.